New Treatment for Lou Gehrig's Disease Shows Promise - The New
4.9
$ 3.99
In stock
(540)
Product Description
FDA approves new drug to treat ALS-Lou Gehrig's disease
Potential ALS Therapy Based on Cancer Treatment Rituximab Shows
Blood Test Shows Promise for Quick Diagnosis of ALS
Updated Data Show Promise of Targeted Therapy in Castleman Disease
FDA Approves Biogen's Qalsody for Treatment of SOD1-ALS - Quest
ALS: Parkinson's drug ropinirole may be an effective treatment
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month - WSJ
ALS: Parkinson's drug ropinirole may be an effective treatment
ALS patients eye new drug showing success in delaying disease
Silencing a faulty gene may uncover clues to rare forms of ALS
New preclinical study shows antibody therapy could offer treatment
A Better Future for ALS Patients - WSJ
